Cafepharma Today

Valeant backlash continues, as ex-President de Silva ousted from Endo after only a few months, a device rep speaks about an acquistion gone wrong, more aftermath of the Sarepta DMD drug ruling, and more - scroll down for the latest news

Thursday's most active boards: Novo Nordisk, AstraZeneca, Sanofi,

Thursday's most active thread (Novo Nordisk): Headcount reductions being finalized

Should the government be involved in drug pricing? Come discuss on the CP group discussion board

click here for the latest message board posts
click here for the latest on pharma/biotech social media
click here for the latest on med device social media

Current News

Saturday, September 24, 2016 - 1:42pm
Motley Fool
Saturday, September 24, 2016 - 1:40pm
Motley Fool
Saturday, September 24, 2016 - 1:34pm
Market Realist
Saturday, September 24, 2016 - 1:31pm
Saturday, September 24, 2016 - 1:29pm
Motley Fool
Friday, September 23, 2016 - 10:11pm
Friday, September 23, 2016 - 10:10pm
Friday, September 23, 2016 - 10:06pm
Friday, September 23, 2016 - 9:56am
Mass Device
Friday, September 23, 2016 - 9:51am
Seeking Alpha
Friday, September 23, 2016 - 9:46am
FDA Voice
Thursday, September 22, 2016 - 9:21am
Thursday, September 22, 2016 - 9:17am

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Breaking Healthcare News - powered by Seeking Alpha

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Latest social media